Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.
about
Human CD4+CD25+ regulatory T cells are sensitive to low dose cyclophosphamide: implications for the immune response.Mobilization with cyclophosphamide reduces the number of lymphocyte subpopulations in the leukapheresis product and delays their reconstitution after autologous hematopoietic stem cell transplantation in patients with multiple myeloma.In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen.
P2860
Immune recovery after cyclophosphamide treatment in multiple myeloma: implication for maintenance immunotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Immune recovery after cyclopho ...... for maintenance immunotherapy.
@en
type
label
Immune recovery after cyclopho ...... for maintenance immunotherapy.
@en
prefLabel
Immune recovery after cyclopho ...... for maintenance immunotherapy.
@en
P2860
P356
P1433
P1476
Immune recovery after cyclopho ...... for maintenance immunotherapy
@en
P2093
Nechama Haran-Ghera
P2860
P304
P356
10.1155/2011/269519
P50
P577
2011-04-06T00:00:00Z